ClinicalTrials.Veeva

Menu

Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Myopia

Study type

Observational

Funder types

Other

Identifiers

NCT01481792
AUH-Ophthalmology-2011-01

Details and patient eligibility

About

Evaluation of the safety and efficacy of the Carl Zeiss Meditec VisuMax femtosecond laser for lamellar resection (ReLEx smile) in the reduction of myopia.

Full description

Quality control study of patients treated with ReLEx smile for myopia at the Department of Ophthalmology, Aarhus University Hospital.

The patients will be followed with standard clinical techniques (slit-lamp examination, refraction, topography) during their normal follow-up up to 12 months after treatment.

Enrollment

125 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for keratorefractive correction of myopia
  • Patient consent to undergo keratorefractive correction of myopia

Exclusion criteria

  • Pregnant or lactating women

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems